{
    "clinical_study": {
        "@rank": "51825", 
        "arm_group": [
            {
                "arm_group_label": "Sodium bicarbonate", 
                "arm_group_type": "Experimental", 
                "description": "Sodium Bicarbonate (154 mEq/L in dextrose and H2O) 3 mL/kg for 1 hour before contrast medium, followed by an infusion of 1 mL/kg/h for 12 hours after the procedure"
            }, 
            {
                "arm_group_label": "Saline", 
                "arm_group_type": "Active Comparator", 
                "description": "Sodium Saline 3 mL/kg for 1 hour before contrast medium, followed by an infusion of 1 mL/kg/h for 12 hours after the procedure"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether hydration with sodium bicarbonate is more\n      effective than hydration with sodium chloride to prevent contrast nephropathy in patients\n      undergoing primary coronary intervention for acute ST elevation myocardial infarction."
        }, 
        "brief_title": "Early Hydration in Acute Myocardial Infarction", 
        "completion_date": {
            "#text": "October 2013", 
            "@type": "Actual"
        }, 
        "condition": "Contrast Induced Acute Kidney Injury", 
        "condition_browse": {
            "mesh_term": [
                "Infarction", 
                "Acute Kidney Injury", 
                "Myocardial Infarction", 
                "Wounds and Injuries"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Consecutive patients with AMI candidates for primary PCI presenting within 12 h of\n             symptom onset with ST-segment elevation of more 1 mm in at least two contiguous leads\n             of electrocardiogram.\n\n        Exclusion Criteria:\n\n          -  contrast medium administration within the 10 days\n\n          -  end-stage renal failure requiring dialysis\n\n          -  refusal to give informed consent"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "300", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 2, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01742130", 
            "org_study_id": "Prato0705"
        }, 
        "intervention": [
            {
                "arm_group_label": "Sodium bicarbonate", 
                "intervention_name": "sodium bicarbonate solution", 
                "intervention_type": "Drug", 
                "other_name": "154 mEq/L in dextrose and H2O"
            }, 
            {
                "arm_group_label": "Saline", 
                "intervention_name": "Isotonic saline", 
                "intervention_type": "Drug", 
                "other_name": "0.9% sodium chloride"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Contrast-induced nephropathy", 
            "Contrast media", 
            "Angiography", 
            "Coronary percutaneous intervention"
        ], 
        "lastchanged_date": "November 5, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Prato", 
                    "country": "Italy", 
                    "zip": "59100"
                }, 
                "name": "Ospedale Misericordia e Dolce"
            }
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_arms": "2", 
        "official_title": "Early Hydration in Acute Myocardial Infarction: Sodium Bicarbonate Versus Saline for the Prevention on Contrast-induced Acute Kidney Injury", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Italy: National Bioethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "October 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "contrast-induced acute kidney injury is defined as an increase in serum creatinine >= 0.3 mg/dL over the baseline value within 2 days after the administration of the contrast medium", 
            "measure": "Incidence of contrast-induced acute kidney injury", 
            "safety_issue": "Yes", 
            "time_frame": "2 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01742130"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ospedale Misericordia e Dolce", 
            "investigator_full_name": "Mauro Maioli", 
            "investigator_title": "Medical Doctor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "adverse clinical events within 1 month including in-hospital death and need for dialysis or hemofiltration", 
            "measure": "adverse clinical events", 
            "safety_issue": "Yes", 
            "time_frame": "1 month"
        }, 
        "source": "Ospedale Misericordia e Dolce", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ospedale Misericordia e Dolce", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}